Robbins Geller Rudman & Dowd Breaking News Pan-Cancer Study Suggests 'RBness' Tumors Share Features with RB1-Defective Cancers Genomic Data Analytics Firm Galatea Bio Raises $25M Mainz Biomed Launches Study for Colon Cancer Screening Test, Aiming for Added Sensitivity US Department of Health and Human Services to Lay Off 10K Workers in Restructuring 23andMe Asset Sale Approved by Bankruptcy Court
